Figure 6.
ST reveals microenvironmental differences between therapy-responsive and therapy-resistant patients. (A-C) Leiden clustering of spots based on the cell type abundances for PT07 (A), PT08 (B), and PT10B (C). (D) Maximum-intensity projection (MIP) and transaxial [18F] fluorodesoxyglucose (FDG) positron emission tomography/computed tomography. The leftmost panels show PT07 at baseline and multiple lesions on both sides are indicated by arrowheads. In the middle panel, after talquetamab treatment, a follow-up scan was conducted 14 months later. A punch biopsy was taken from the lesion indicated by the circle. The rightmost panels display a follow-up scan after 20 months. Arrows indicate location of biopsied lesion. (E-G) Cell type abundances of PCs, macrophages M1, CD8+ T cytotoxic, and T-cells Tim3+ for PT07 (E), PT08 (F), and PT10B (G). (H) Cell type abundance comparing PCs, macrophages M1, and T-cells Tim3+ in all patients. Pairwise comparisons were implemented using the Wilcoxon test; ∗∗∗P < .001.

ST reveals microenvironmental differences between therapy-responsive and therapy-resistant patients. (A-C) Leiden clustering of spots based on the cell type abundances for PT07 (A), PT08 (B), and PT10B (C). (D) Maximum-intensity projection (MIP) and transaxial [18F] fluorodesoxyglucose (FDG) positron emission tomography/computed tomography. The leftmost panels show PT07 at baseline and multiple lesions on both sides are indicated by arrowheads. In the middle panel, after talquetamab treatment, a follow-up scan was conducted 14 months later. A punch biopsy was taken from the lesion indicated by the circle. The rightmost panels display a follow-up scan after 20 months. Arrows indicate location of biopsied lesion. (E-G) Cell type abundances of PCs, macrophages M1, CD8+ T cytotoxic, and T-cells Tim3+ for PT07 (E), PT08 (F), and PT10B (G). (H) Cell type abundance comparing PCs, macrophages M1, and T-cells Tim3+ in all patients. Pairwise comparisons were implemented using the Wilcoxon test; ∗∗∗P < .001.

or Create an Account

Close Modal
Close Modal